Applications of transcranial magnetic stimulation in migraine: evidence from a scoping review
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Transcranial magnetic stimulation (TMS), a non-invasive brain stimulation method, is trying to emerge as a migraine management strategy for both attack treatment and prevention. This scoping review presents 16 among single-pulse (to manage episodic and chronic migraine) and repetitive TMS randomized clinical trials (to manage chronic migraine). The works we reviewed suggest that TMS may be adopted as add-on therapy in those patients who are refractory to pharmacological therapy only with special arrangements for individualized treatment strategies or research. There are still limited clinical research programs and metaanalysis to promote routinely TMS employment, as TMS has been shown either to have no significant effects for any outcome or to be effective for migraine. These diverging conclusions depend on several biasing factors, including the lack of reliable, large, sham-controlled clinical trials, the dyshomogeneity in study designs (including the area of stimulation, the frequency of stimulation, the number of pulses, pulse intensity, and the number of sessions), patient selection criteria (migraine w/o aura, episodic and chronic migraine; TMS contraindication), and the lack of outcomes homogeneity and long-term real-world efficacy data. Therefore, in the future, it will be important to conduct larger randomized trials to confirm TMS usefulness in migraine management (acute attack and prophylactic treatment), identify those patients who may benefit from TMS, maybe independently of pharmacological treatments (i.e., using TMS as an alternative and not only as an add-on treatment). Otherwise, TMS will play a role in treating migraine only with special arrangements for individualized management strategies or research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In obsessive–compulsive disorder (OCD), stimulation of the medial prefrontal cortex and anterior cingulate cortex produces significant reductions in Yale-brown obsessive-compulsive scores (Y-BOCS) and is associated with improved error-monitoring processes [102,113,114,115].”
From The Heart’s Electromagnetic Field in Emotions, Empathy and Human Connection: Biosensor-Derived Insights into Heart–Brain Axis Mechanisms and a Basis for Novel BioMagnetoTherapies (2026) · cites this paper as [115]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ
Tong, A., Flemming, K., McInnes, E., Oliver, S., & Craig, J. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-181 · Cited by 3,569 · cited 1×
“This literature review was developed according to the guidance for narrative syntheses [11,12] and the Enhancing Transparency in Reporting the Synthesis of Qualitative Research (ENTREQ) reporting guidelines [13].”
MethodPathophysiology of migraine: a disorder of sensory processing
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00034.2015 · Cited by 1,998 · cited 2×
“The physiopathology of migraine is complex (including several biochemical cascades, the cortical spreading depression phenomenon, and an enhanced central sensitization) and still partially unknown [3].”
BackgroundLipton, R. B., Dodick, D. W., Silberstein, S. D., Saper, J. R., Aurora, S. K., Pearlman, S. H., Fischell, R. E., Ruppel, P. L., & Goadsby, P. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70054-5 · Cited by 465 · cited 3×
“Lipton 2010 [15] sTMS inion 164 EM (MA) randomized Significant lack of ma episodes up to 48”
MethodTranscranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine
Aurora, S. K., Ahmad, B. K., Welch, K. M. A., Bhardhwaj, P., & Ramadan, N. M. (1998) · Neurology · doi:10.1212/wnl.50.4.1111 · Cited by 350
tDCS‐Induced Analgesia and Electrical Fields in Pain‐Related Neural Networks in Chronic Migraine
DaSilva, A. F., Mendonca, M. E., Zaghi, S., Lopes, M., DosSantos, M. F., Spierings, E. L., Bajwa, Z., Datta, A., Bikson, M., & Fregni, F. (2012) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02141.x · Cited by 305
Recent advances in the treatment of chronic pain with non-invasive brain stimulation techniques
Fregni, F., Freedman, S., & Pascual-Leone, A. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70032-7 · Cited by 299 · cited 1×
“All these issues justify the potentially positive response of patients with migraine with or without aura to rTMS, which has been estimated putatively capable of reverting the mentioned above (mal) adaptive plasticity in chronic pain conditions [63,64].”
BackgroundrTMS of the prefrontal cortex in the treatment of chronic migraine: A pilot study
Brighina, F., Piazza, A., Vitello, G., Aloisio, A., Palermo, A., Daniele, O., & Fierro, B. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.08.008 · Cited by 269 · cited 2×
“A 20 Hz-rTMS study over left M1 was shown to reduce attack frequency, headache index, and the number of abortive pills used for up to 2 months [26].”
MethodNeuromodulation of chronic headaches: position statement from the European Headache Federation
Martelletti, P., Jensen, R. H., Antal, A., Arcioni, R., Brighina, F., de Tommaso, M., Franzini, A., Fontaine, D., Heiland, M., Jürgens, T. P., et al. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-86 · Cited by 210
Alteration of cortical excitability in patients with fibromyalgia
Mhalla, A., de Andrade, D. C., Baudic, S., Perrot, S., & Bouhassira, D. (2010) · Pain · doi:10.1016/j.pain.2010.03.009 · Cited by 209 · cited 1×
“Furthermore, the baseline activity of such brain areas, which seems largely abnormal in chronic pain conditions [59,60], has been proposed to tune other pain-associated neural areas [61].”
BackgroundAdvances and challenges in neurostimulation for headaches
Magis, D., & Schoenen, J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70139-4 · Cited by 196 · cited 1×
“Furthermore, the response rate for TMS seems to be not superior to that of the preventive drug treatment [76].”
BackgroundThe Occipital Cortex Is Hyperexcitable in Migraine: Experimental Evidence
Aurora, S., Cao, Y., Bowyer, S., & Welch, K. M. A. (1999) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1999.3907469.x · Cited by 194
A prospective real-world analysis of erenumab in refractory chronic migraine
Lambru, G., Hill, B., Murphy, M., Tylova, I., & Andreou, A. P. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01127-0 · Cited by 182
Brighina, F., Piazza, A., Daniele, O., & Fierro, B. (2002) · Experimental Brain Research · doi:10.1007/s00221-002-1096-7 · Cited by 164
Starling, A. J., Tepper, S. J., Marmura, M. J., Shamim, E. A., Robbins, M. S., Hindiyeh, N., Charles, A. C., Goadsby, P. J., Lipton, R. B., Silberstein, S. D., et al. (2018) · Cephalalgia · doi:10.1177/0333102418762525 · Cited by 162 · cited 2×
“in acute medication use and disability [29].”
BackgroundPrimary headaches during lifespan
Straube, A., & Andreou, A. P. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0985-0 · Cited by 158 · cited 1×
“Migraine is one of the primary headaches according to the International Classification of Headache Disorder third edition (ICHD-3) beta, affecting about 15% of the population and causing severe impairment of the quality of life [1].”
BackgroundAndreou, A. P., Holland, P. R., Akerman, S., Summ, O., Fredrick, J., & Goadsby, P. J. (2016) · Brain · doi:10.1093/brain/aww118 · Cited by 145 · cited 2×
“Another contribution to TMS efficacy in migraine with aura may come from a blocking action onto the activity of third-order neurons in the VPM thalamic nucleus, potentially through reverberant cortico-thalamocortical loops [9].”
BackgroundBhola, R., Kinsella, E., Giffin, N., Lipscombe, S., Ahmed, F., Weatherall, M., & Goadsby, P. J. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0535-3 · Cited by 138 · cited 1×
“The subjects reported a significant clinical improvement in 62% of patients, including the reduction in monthly headache days and attack duration in both episodic and chronic migraine, in addition to a reduction in disability [32].”
BackgroundLow-frequency rTMS of the vertex in the prophylactic treatment of migraine
Teepker, M., Hötzel, J., Timmesfeld, N., Reis, J., Mylius, V, Haag, A., Oertel, W., Rosenow, F., & Schepelmann, K. (2010) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01911.x · Cited by 136 · cited 3×
“The number of migraine attacks and days did not differ significantly between real and sham low-frequency rTMS [17].”
BackgroundConforto, A. B., Amaro, E., Gonçalves, A. L., Mercante, J. P., Guendler, V. Z., Ferreira, J. R., Kirschner, C. C., & Peres, M. F. (2014) · Cephalalgia · doi:10.1177/0333102413515340 · Cited by 125 · cited 2×
“Thus, M1 stimulationwith rTMS seems a more promising target than the DLPFC does [23].”
BackgroundDistinctive anatomical and physiological features of migraine aura revealed by 18 years of recording
Hansen, J. M., Baca, S. M., VanValkenburgh, P., & Charles, A. C. (2013) · Brain · doi:10.1093/brain/awt309 · Cited by 122 · cited 1×
“Regarding migraine with aura, TMS is proposed to challenge the spread of cortical spreading depolarization, particularly when applied over the occipital cortex [72].”
BackgroundTranscranial magnetic stimulation for migraine: clinical effects
Clarke, B. M., Upton, A. R. M., Kamath, M. V., Al-Harbi, T., & Castellanos, C. M. (2006) · The Journal of Headache and Pain · doi:10.1007/s10194-006-0329-8 · Cited by 120 · cited 4×
“The percentage of patients complaining of migraine relief, mainly those among migraine with aura, increased with increasing stimulation rounds, suggesting a cumulative effect of sTMS, which was used to treat episodic migraine [14].”
BackgroundMethodInfluentialTranscranial Magnetic Stimulation: Basic Principles and Clinical Applications in Migraine
Barker, A. T., & Shields, K. G. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13002 · Cited by 115 · cited 2×
“Migraine reduction improves while increasing the number and intensity of stimuli, suggesting a cumulative effect of TMS stimuli consistently with neuroplasticity principles [47]; however, this is not an absolute rule as sham TMS outperformed real TMS in some clinical trials.”
BackgroundMapping migraine to a common brain network
Burke, M. J., Joutsa, J., Cohen, A. L., Soussand, L., Cooke, D., Burstein, R., & Fox, M. (2019) · Brain · doi:10.1093/brain/awz405 · Cited by 104
Facilitatory effects of 1�Hz rTMS in motor cortex of patients affected by migraine with aura
Brighina, F., Giglia, G., Scalia, S., Francolini, M., Palermo, A., & Fierro, B. (2004) · Experimental Brain Research · doi:10.1007/s00221-004-2042-7 · Cited by 103
Role of the primary motor cortex in the maintenance and treatment of pain in fibromyalgia
Saavedra, L. C., de Mendonça, M. E., & Fregni, F. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.06.007 · Cited by 92 · cited 1×
“Furthermore, the baseline activity of such brain areas, which seems largely abnormal in chronic pain conditions [59,60], has been proposed to tune other pain-associated neural areas [61].”
BackgroundTranscranial Magnetic Stimulation for Migraine: A Safety Review
Dodick, D. W., Schembri, C. T., Helmuth, M., & Aurora, S. K. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01697.x · Cited by 90 · cited 1×
“In addition, TMS is safe and welltolerated, also considering that the majority of trials employed subthreshold stimulation intensities, as only mild light-headedness, tinnitus, dizziness, paresthesia, tinnitus, scalp discomfort, and worsening of migraine have been reported [38].”
BackgroundBurch, R. C. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000957 · Cited by 77
Abnormal facilitatory mechanisms in motor cortex of migraine with aura
Brighina, F., Cosentinol, G., Vigneri, S., Talamanca, S., Palermo, A., Giglia, G., & Fierro, B. (2011) · European Journal of Pain · doi:10.1016/j.ejpain.2011.03.012 · Cited by 76
Shirahige, L., Melo, L., Nogueira, F., Rocha, S., & Monte‐Silva, K. (2016) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12981 · Cited by 69 · cited 1×
“Some reviews and meta-analyses concluded that TMS has no significant effects for any outcome [7,8,36], whereas other reviews proposed that TMS is effective for migraine, although admitting that there is still insufficient evidence to promote its large-scale use in clinical settings [4–6,37].”
BackgroundTepe, N., Filiz, A., Dileköz, E., Akçalı, D. T., Sara, Y., Charles, A. C., & Bolay, H. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12753 · Cited by 68 · cited 1×
“Therefore, more randomized controlled trials are required to clarify the migraine pathophysiology (particularly the cortical spreading depression and the thalamocortical cross-talk) [77], possibly adopting simultaneously or deferred functional neuroimaging and neurophysiological studies methods, and analyze the safety…”
BackgroundKalita, J., Laskar, S., Bhoi, S. K., & Misra, U. K. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8257-2 · Cited by 65 · cited 2×
“Notably, providing the patients with three of these sessions was not significantly superior to the single session [22].”
BackgroundEmerging drugs for migraine treatment: an update
Lambru, G., Andreou, A. P., Guglielmetti, M., & Martelletti, P. (2018) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2018.1552939 · Cited by 58
Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open‐Label Study
Irwin, S. L., Qubty, W. F., Allen, I. E., Patniyot, I. R., Goadsby, P. J., & Gelfand, A. A. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13284 · Cited by 57
Shehata, H., Esmail, E., Abdelalim, A., El-Jaafary, S. I., Elmazny, A. N., Sabbah, A., & Shalaby, N. (2016) · Journal of Pain Research · doi:10.2147/jpr.s116671 · Cited by 56 · cited 2×
“High-frequency rTMS (10 Hz, 2000 pulses per session) over the leftM1was not superior to botulinum toxin-A injection up to 8 weeks post-treatment, but it was less effective at 12 weeks [25].”
BackgroundMisra, U. K., Kalita, J., & Bhoi, S. K. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000045 · Cited by 54 · cited 3×
“Instead, a single session of high-frequency rTMS (600 pulses at 10 Hz) over the left primary motor cortex (M1) reduced the number of headache days per month (of about 3 days), the migraine attack intensity, the quality of life impairment, and the painkiller intake, particularly within the first two weeks after the par…”
BackgroundMethodInfluentialGranato, A., Fantini, J., Monti, F., Furlanis, G., Ilbeh, S. M., Semenic, M., & Manganotti, P. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.09.021 · Cited by 54 · cited 1×
“However, over and above that, high-frequency rTMS carries a high potential of inducing a placebo effect, which can be usefully leveraged to enhance patients’ coping strategies [70].”
BackgroundKumar, A., Mattoo, B., Bhatia, R., Kumaran, S. S., & Bhatia, R. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04505-3 · Cited by 54 · cited 2×
“Kumar 2021 [24] 10 × 10 Hz 600p 70% RMT left M1 20 CM randomized significant reduction of migraine severity”
BackgroundEvoked potentials in large-scale cortical networks elicited by TMS of the visual cortex
Garcia, J. O., Grossman, E. D., & Srinivasan, R. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00739.2010 · Cited by 53
Conte, A., Barbanti, P., Frasca, V., Iacovelli, E., Gabriele, M., Giacomelli, E., Aurilia, C., Pichiorri, F., Gilio, F., & Inghilleri, M. (2009) · Pain · doi:10.1016/j.pain.2009.09.031 · Cited by 52
Non-invasive Brain Stimulation, a Tool to Revert Maladaptive Plasticity in Neuropathic Pain
Naro, A., Milardi, D., Russo, M., Terranova, C., Rizzo, V., Cacciola, A., Marino, S., Calabrò, R. S., & Quartarone, A. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00376 · Cited by 52
Self-citationAndreou, A. P., Trimboli, M., Al-Kaisy, A. A., Murphy, M., Palmisani, S., Fenech, C., Smith, T., & Lambru, G. (2018) · European Journal of Neurology · doi:10.1111/ene.13657 · Cited by 49
O'Reardon, J. P., Fontecha, J. F., Cristancho, M. A., & Newman, S. (2007) · CNS Spectrums · doi:10.1017/s1092852900015716 · Cited by 40 · cited 2×
“O’Reardon 2007 [16] 10 Hz 3000p 120% AMT left DLPFC 2 MDD with CM case-report decrease in the number of headache days”
BackgroundMethodThe role of erenumab in the treatment of migraine
Andreou, A. P., Fuccaro, M., & Lambru, G. (2020) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286420927119 · Cited by 40
Cosentino, G., Fierro, B., Vigneri, S., Talamanca, S., Palermo, A., Puma, A. R., & Brighina, F. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01893.x · Cited by 34
Modulation of visual cortex excitability in migraine with aura: Effects of valproate therapy
Palermo, A., Fierro, B., Giglia, G., Cosentino, G., Puma, A. R., & Brighina, F. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.054 · Cited by 32
Sahu, A. K., Sinha, V. K., & Goyal, N. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_472_18 · Cited by 31 · cited 2×
“Two other studies applying 5 Hz [19] and intermittent theta-burst [20] stimulation of the left DLPFC showed partially positive data in the primary outcome (i.”
ResultRapinesi, C., CASALE, A. D., Scatena, P., Kotzalidis, G. D., Pietro, S. D., Ferri, V. R., Bersani, F. S., Brugnoli, R., Raccah, R. N., Zangen, A., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.058 · Cited by 30 · cited 1×
“The authors reported that high-frequency deep TMS of both DLPFCs was more effective than the standard pharmacological treatment alone in reducing the frequency and intensity of migraine attacks, drug overuse, and depressive symptoms, thus resulting as a potentially helpful add-on strategy in chronic migraine [34].”
BackgroundCosentino, G., Marco, S. D., Ferlisi, S., Valentino, F., Capitano, W. M., Fierro, B., & Brighina, F. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0897-4 · Cited by 29
Non-Invasive Neurostimulation Methods for Acute and Preventive Migraine Treatment—A Narrative Review
Evers, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153302 · Cited by 27
Clark, O., Mahjoub, A., Osman, N., Surmava, A.-M., Jan, S., & Lagman‐Bartolome, A. M. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05664-7 · Cited by 26
Increased migraine-free intervals with multifocal repetitive transcranial magnetic stimulation
Leahu, P., Bange, M., Ciolac, D., Scheiter, S., Matei, A., González‐Escamilla, G., Chirumamilla, V. C., Groppa, S. A., Muthuraman, M., & Groppa, S. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.10.383 · Cited by 23 · cited 2×
“Leahu 2021 [28] 13 × 67 Hz 140p 60% RMT swiping”
BackgroundPelka, R. B., Jaenicke, C., & Gruenwald, J. (2001) · Advances in Therapy · doi:10.1007/bf02850298 · Cited by 22 · cited 1×
“[31] adopted a global magnetic field with good results in terms of attack interruption.”
BackgroundConforto, A. B., de Moraes, M. S., Amaro, E., Young, W. B., Lois, L., Gonçalves, A. L., & Peres, M. F. P. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-011-0379-4 · Cited by 22
Noninvasive Neuromodulation in Migraine
Blech, B., & Starling, A. J. (2020) · Current Pain and Headache Reports · doi:10.1007/s11916-020-00914-3 · Cited by 21 · cited 2×
“Notably, it seems that magnetic pulses could inhibit the cortical spreading depression and the related thalamocortical signaling [9], consistently with the evidence that targeting some brain areas with TMS may interfere with pain [8], thus blocking migraine attack and contributing to reducing migraine pain and frequen…”
BackgroundThe Effect of Prophylactic Medications on TMS for Migraine Aura
Almaraz, A. C., Dilli, E., & Dodick, D. W. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01787.x · Cited by 20
A Randomized Controlled Trial of High Rate rTMS Versus rTMS and Amitriptyline in Chronic Migraine
Kalita, J., Kumar, S., Singh, V. K., & Misra, U. K. (2021) · Pain Physician · doi:10.36076/ppj.2021.24.e733 · Cited by 20
Non-Invasive Neuromodulation for Headache Disorders
Zhu, S., & Marmura, M. J. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0620-7 · Cited by 19
The role of left prefrontal transcranial magnetic stimulation in episodic migraine prophylaxis
Amin, R. M., Emara, T., Ashour, S., Hemeda, M., Eldin, N. S., Hamed, S., Shouman, S., & Shouman, M. G. (2020) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-019-0140-5 · Cited by 19 · cited 2×
“Two other studies applying 5 Hz [19] and intermittent theta-burst [20] stimulation of the left DLPFC showed partially positive data in the primary outcome (i.”
MethodResultNon-invasive cortical modulation of experimental pain in migraine
Uglem, M., Omland, P. M., Engstrøm, M., Gravdahl, G. B., Linde, M., Hagen, K., & Sand, T. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2016.03.016 · Cited by 17 · cited 1×
“Similarly, thermal pain measures and cold and heat pain threshold are largely abnormal in migraineurs compared to healthy controls, suggesting a reduced intracortical inhibition and a hypofunction of inhibitory pain modulation mechanisms [62].”
BackgroundMwamburi, M., Liebler, E. J., & Tenaglia, A. T. (2017) · PubMed · Cited by 16
Brüggenjürgen, B., Baker, T., Bhogal, R., & Ahmed, F. (2016) · SpringerPlus · doi:10.1186/s40064-016-2924-8 · Cited by 15
Noninvasive Neuromodulation in Headache: An Update
Lloyd, J. O., Biloshytska, M. V., Andreou, A. P., & Lambru, G. (2021) · Neurology India · doi:10.4103/0028-3886.315998 · Cited by 15
A feasible repetitive transcranial magnetic stimulation clinical protocol in migraine prevention
Zardouz, S., Shi, L., & Leung, A. (2016) · SAGE Open Medical Case Reports · doi:10.1177/2050313x16675257 · Cited by 13 · cited 2×
“Lastly, cortical TMS may modulate thalamus and hypothalamus activity by entraining motor cortex projections to the medial thalamus and the anterior cingulate/orbitofrontal cortices, with relevant consequences on endogenous painkiller mechanisms [71].”
BackgroundHulla, R., & Dougall, A. L. (2019) · Cephalalgia Reports · doi:10.1177/2515816319889971 · Cited by 12 · cited 1×
“TMS seems more effective when applied to the M1 than to the DLPFC or the vertex [48], although the research of TMS over the DLPFC is growing [49].”
MethodNeuromodulation in Headache and Facial Pain Management: Principles, Rationale and Clinical Data
(2019) · Headache · doi:10.1007/978-3-030-14121-9 · Cited by 11 · cited 1×
“macological therapy, thus limiting the generalizability of the present findings to the entire migraine population [51].”
BackgroundGrünner, O. (1985) · Klinische Neurophysiologie · doi:10.1055/s-2008-1060988 · Cited by 9 · cited 1×
“sTMS was initially applied as an alternating real and sham pulsed magnetic field to different scalp sites, including the occipital region, in 40 patients with headache (thus, not only migraine), with positive results in terms of headache frequency and intensity reduction [30].”
MethodSafiai, N. I. M., Amir, N. A., Basri, H., Mat, L. N. I., Hoo, F. K., Khan, A. H. K. Y., Loh, W. C., Chia, P. K., Ramachandran, V., Din, H. M., et al. (2020) · Trials · doi:10.1186/s13063-020-04832-y · Cited by 9 · cited 1×
“TMS seems more effective when applied to the M1 than to the DLPFC or the vertex [48], although the research of TMS over the DLPFC is growing [49].”
MethodNaeije, G., Fogang, Y. F., Ligot, N., & Mavroudakis, N. (2017) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2017.05.093 · Cited by 8
Repetitive transcranial magnetic stimulation as a prophylactic treatment in migraine
Hammad, A. B., Elsharkawy, R. E., & Azim, G. S. A. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-020-00254-4 · Cited by 7 · cited 2×
“Hammad 2021 [18] 2 × 1 Hz 500p 100% RMT vertex 65 EM (MA-MO) open label significant reduction in pain intensity,”
BackgroundLow-frequency rTMS of the vertex in the prophylactic treatment of migraine
Teepker, M., Hötzel, J., Timmesfeld, N., Reis, J., Mylius, V., Haag, A., Oertel, W., Rosenow, F., & Schepelmann, K. (2008) · Klinische Neurophysiologie · doi:10.1055/s-2008-1072806 · Cited by 3
Wong, H. T., & Ahmed, F. (2019) · Headache · doi:10.1007/978-3-030-14121-9_18 · Cited by 2
Safiai, N. I. M., Amir, N. A., Basri, H., et al. (2020) · Research Square · doi:10.21203/rs.2.23373/v1 · Cited by 1
Research works printed but not linked: 2
- Holland PR, Schembri C, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation for the treatment of migraine aura? Cephalalgia. 2009; 29: 22.
- Conforto A, Gonçalves AL, Mercante J, Guendler V, Amaro Jr E, Moraes M, et al. Effects of repetitive transcranial magnetic stimulation in chronic migraine: A pilot study. Cephalalgia. 2011; 31: 94.
Cited by
Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: A meta-analysis
Zhong, J., Lan, W., Feng, Y., Yu, L., Xiao, R., Shen, Y., Zou, Z., & Hou, X. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1050090 · Cited by 30
Nonpharmacological modulation of cortical spreading depolarization
Nash, C., Powell, K., Lynch, D. G., Hartings, J. A., & Li, C. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121833 · Cited by 11
Palantzas, A., & Anagnostouli, M. (2026) · Sensors · doi:10.3390/s26051738 · Cited by 1
“In obsessive–compulsive disorder (OCD), stimulation of the medial prefrontal cortex and anterior cingulate cortex produces significant reductions in Yale-brown obsessive-compulsive scores (Y-BOCS) and is associated with improved error-monitoring processes [102,113–115].”
Actualización del tratamiento de migraña
Naspud, N. M. A., León, R. S. C., Suña, C. A. C., Rivera, G. E. C., & Basurto, B. S. S. (2024) · doi:10.58995/lb.redlic.26.199
Investigación contemporánea desde una visión multidisciplinar. Libro 4. Ciencias de la Salud
SAS), R. E. L. D. I. C. (. (2024) · doi:10.58995/lb.redlic.26
Metadata
- Authors
- Calabrò, R. S., Billeri, L., Manuli, A., Iacono, A., & Naro, A.
- Affiliations
- Centro Neurolesi Bonino Pulejo (IT)
- Istituto Clinico Polispecialistico, C.O.T. Cure Ortopediche Traumatologiche s.p.a., 98124 Messina, Italy
- Azienda Ospedaliera Universitaria Policlinico "G. Martino" (IT)
- Ospedale Vincenzo Cervello (IT)
- Venue
- Journal of Integrative Neuroscience
- Publisher
- IMR Press
- Published
- 2022-06-07
- Volume
- 21
- Issue
- 4
- Pages
- 110-110
- ISSN
- 0219-6352 (ISSN-L)
- 1757-448X
- OpenAlex
- W4281746620
- Cited by
- 9
- References
- 74
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Integrative Neuroscience (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
- Keywords
- transcranial magnetic stimulation, migraine, chronic migraine, episodic migraine, migraine prophylaxis, acute migraine treatment, repetitive TMS, single-pulse TMS, adjunctive therapy, treatment-resistant migraine, stimulation parameters, personalized treatment
- MeSH terms
- Brain, Chronic Disease, Humans, Migraine Disorders, Migraine with Aura, Transcranial Magnetic Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
